Hak A E, Pols H A, Visser T J, Drexhage H A, Hofman A, Witteman J C
Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
Ann Intern Med. 2000 Feb 15;132(4):270-8. doi: 10.7326/0003-4819-132-4-200002150-00004.
Overt hypothyroidism has been found to be associated with cardiovascular disease. Whether subclinical hypothyroidism and thyroid autoimmunity are also risk factors for cardiovascular disease is controversial.
To investigate whether subclinical hypothyroidism and thyroid autoimmunity are associated with aortic atherosclerosis and myocardial infarction in postmenopausal women.
Population-based cross-sectional study.
A district of Rotterdam, The Netherlands.
Random sample of 1149 women (mean age +/- SD, 69.0 +/- 7.5 years) participating in the Rotterdam Study.
Data on thyroid status, aortic atherosclerosis, and history of myocardial infarction were obtained at baseline. Subclinical hypothyroidism was defined as an elevated thyroid-stimulating hormone level (>4.0 mU/L) and a normal serum free thyroxine level (11 to 25 pmol/L [0.9 to 1.9 ng/dL]). In tests for antibodies to thyroid peroxidase, a serum level greater than 10 IU/mL was considered a positive result.
Subclinical hypothyroidism was present in 10.8% of participants and was associated with a greater age-adjusted prevalence of aortic atherosclerosis (odds ratio, 1.7 [95% CI, 1.1 to 2.6]) and myocardial infarction (odds ratio, 2.3 [CI, 1.3 to 4.0]). Additional adjustment for body mass index, total and high-density lipoprotein cholesterol level, blood pressure, and smoking status, as well as exclusion of women who took beta-blockers, did not affect these estimates. Associations were slightly stronger in women who had subclinical hypothyroidism and antibodies to thyroid peroxidase (odds ratio for aortic atherosclerosis, 1.9 [CI, 1.1 to 3.6]; odds ratio for myocardial infarction, 3.1 [CI, 1.5 to 6.3]). No association was found between thyroid autoimmunity itself and cardiovascular disease. The population attributable risk percentage for subclinical hypothyroidism associated with myocardial infarction was within the range of that for known major risk factors for cardiovascular disease.
Subclinical hypothyroidism is a strong indicator of risk for atherosclerosis and myocardial infarction in elderly women.
已发现显性甲状腺功能减退与心血管疾病有关。亚临床甲状腺功能减退和甲状腺自身免疫是否也是心血管疾病的危险因素仍存在争议。
调查亚临床甲状腺功能减退和甲状腺自身免疫与绝经后女性主动脉粥样硬化和心肌梗死是否相关。
基于人群的横断面研究。
荷兰鹿特丹的一个区。
参与鹿特丹研究的1149名女性的随机样本(平均年龄±标准差,69.0±7.5岁)。
在基线时获取甲状腺状态、主动脉粥样硬化和心肌梗死病史的数据。亚临床甲状腺功能减退定义为促甲状腺激素水平升高(>4.0 mU/L)且血清游离甲状腺素水平正常(11至25 pmol/L [0.9至1.9 ng/dL])。在检测甲状腺过氧化物酶抗体时,血清水平大于10 IU/mL被视为阳性结果。
10.8%的参与者存在亚临床甲状腺功能减退,且与年龄调整后的主动脉粥样硬化患病率较高相关(比值比,1.7 [95%可信区间,1.1至2.6])和心肌梗死患病率较高相关(比值比,2.3 [可信区间,1.3至4.0])。对体重指数、总胆固醇和高密度脂蛋白胆固醇水平、血压和吸烟状况进行额外调整,以及排除服用β受体阻滞剂的女性,均不影响这些估计值。在患有亚临床甲状腺功能减退和甲状腺过氧化物酶抗体的女性中,关联略强(主动脉粥样硬化的比值比,1.9 [可信区间,1.1至3.6];心肌梗死的比值比,3.1 [可信区间,1.5至6.3])。未发现甲状腺自身免疫本身与心血管疾病之间存在关联。与心肌梗死相关的亚临床甲状腺功能减退的人群归因风险百分比在已知心血管疾病主要危险因素的范围内。
亚临床甲状腺功能减退是老年女性动脉粥样硬化和心肌梗死风险 的有力指标。